Atlas Trials

Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

Clinical trial NCT07619560 · RECRUITING

Trial details

NCT number
NCT07619560
Sponsor
Taipei Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Parkinson Disease (PD)Gut MicrobiotaProbiotic
Start date
2025-05-20
Primary completion
2027-08-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.